Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
2006-10-31
pubmed:abstractText
We identify a new mechanism for the beta(1)-adrenergic receptor (beta(1)AR)-mediated regulation of human ether-a-go-go-related gene (HERG) potassium channel (Kv11.1). We find that the previously reported modulatory interaction between Kv11.1 channels and 14-3-3epsilon proteins is competed by wild type beta(1)AR by means of a novel interaction between this receptor and 14-3-3epsilon. The association between beta(1)AR and 14-3-3epsilon is increased by agonist stimulation in both transfected cells and heart tissue and requires cAMP-dependent protein kinase (PKA) activity. The beta(1)AR/14-3-3epsilon association is direct, since it can be recapitulated using purified 14-3-3epsilon and beta(1)AR fusion proteins and is abolished in cells expressing beta(1)AR phosphorylation-deficient mutants. Biochemical and electrophysiological studies of the effects of isoproterenol on Kv11.1 currents recorded using the whole-cell patch clamp demonstrated that beta(1)AR phosphorylation-deficient mutants do not recruit 14-3-3epsilon away from Kv11.1 and display a markedly altered agonist-mediated modulation of Kv11.1 currents compared with wild-type beta(1)AR, increasing instead of inhibiting current amplitudes. Interestingly, such differential modulation is not observed in the presence of 14-3-3 inhibitors. Our results suggest that the dynamic association of 14-3-3 proteins to both beta(1)AR and Kv11.1 channels is involved in the adrenergic modulation of this critical regulator of cardiac repolarization and refractoriness.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/16914520-10224112, http://linkedlifedata.com/resource/pubmed/commentcorrection/16914520-10493820, http://linkedlifedata.com/resource/pubmed/commentcorrection/16914520-10535961, http://linkedlifedata.com/resource/pubmed/commentcorrection/16914520-10654934, http://linkedlifedata.com/resource/pubmed/commentcorrection/16914520-10715269, http://linkedlifedata.com/resource/pubmed/commentcorrection/16914520-10727525, http://linkedlifedata.com/resource/pubmed/commentcorrection/16914520-10836149, http://linkedlifedata.com/resource/pubmed/commentcorrection/16914520-10837251, http://linkedlifedata.com/resource/pubmed/commentcorrection/16914520-11178869, http://linkedlifedata.com/resource/pubmed/commentcorrection/16914520-11278781, http://linkedlifedata.com/resource/pubmed/commentcorrection/16914520-11562432, http://linkedlifedata.com/resource/pubmed/commentcorrection/16914520-11799244, http://linkedlifedata.com/resource/pubmed/commentcorrection/16914520-11827686, http://linkedlifedata.com/resource/pubmed/commentcorrection/16914520-11953308, http://linkedlifedata.com/resource/pubmed/commentcorrection/16914520-12196094, http://linkedlifedata.com/resource/pubmed/commentcorrection/16914520-12591761, http://linkedlifedata.com/resource/pubmed/commentcorrection/16914520-12821660, http://linkedlifedata.com/resource/pubmed/commentcorrection/16914520-15023549, http://linkedlifedata.com/resource/pubmed/commentcorrection/16914520-15121159, http://linkedlifedata.com/resource/pubmed/commentcorrection/16914520-15122248, http://linkedlifedata.com/resource/pubmed/commentcorrection/16914520-15221346, http://linkedlifedata.com/resource/pubmed/commentcorrection/16914520-16336510, http://linkedlifedata.com/resource/pubmed/commentcorrection/16914520-7736582, http://linkedlifedata.com/resource/pubmed/commentcorrection/16914520-7905023, http://linkedlifedata.com/resource/pubmed/commentcorrection/16914520-8601312, http://linkedlifedata.com/resource/pubmed/commentcorrection/16914520-9428519
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1059-1524
pubmed:author
pubmed:issnType
Print
pubmed:volume
17
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
4666-74
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:16914520-14-3-3 Proteins, pubmed-meshheading:16914520-Animals, pubmed-meshheading:16914520-CHO Cells, pubmed-meshheading:16914520-Cricetinae, pubmed-meshheading:16914520-Cricetulus, pubmed-meshheading:16914520-Cyclic AMP-Dependent Protein Kinases, pubmed-meshheading:16914520-Guinea Pigs, pubmed-meshheading:16914520-Heart, pubmed-meshheading:16914520-Humans, pubmed-meshheading:16914520-Ion Channel Gating, pubmed-meshheading:16914520-Isoproterenol, pubmed-meshheading:16914520-Mutant Proteins, pubmed-meshheading:16914520-Mutation, pubmed-meshheading:16914520-Phosphorylation, pubmed-meshheading:16914520-Potassium Channels, Voltage-Gated, pubmed-meshheading:16914520-Protein Binding, pubmed-meshheading:16914520-Receptors, Adrenergic, beta-1, pubmed-meshheading:16914520-Recombinant Proteins, pubmed-meshheading:16914520-Time Factors
pubmed:year
2006
pubmed:articleTitle
Association of 14-3-3 proteins to beta1-adrenergic receptors modulates Kv11.1 K+ channel activity in recombinant systems.
pubmed:affiliation
Departamento de Biología Molecular and Centro de Biología Molecular "Severo Ochoa," Universidad Autónoma de Madrid, 28049 Madrid, Spain.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't